glp-1 chronic kidney disease

glp-1 chronic kidney disease and Cardiovascular Outcomes Among Patients With CKD Receiving Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials New Hope for Kidney Disease:

Name: glp-1 chronic kidney disease and Cardiovascular Outcomes Among Patients With CKD Receiving Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials New Hope for Kidney Disease:
Brand: 2m-capital.com
SKU: 54685557136
Price: 28.80 USD
Availability: InStock
Rating: 4.729900000000001 (21 reviews)

SKU: 54685557136

4.7

USD28.80 USD64.80

Pay in 4 interest-free payments of $7.20 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 8 - Nov 13

Description

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): a systematic review

Genome-wide association study A genome-wide association study (GWAS) of common genetic variants with major effect on warfarin maintenance dose, performed by Cooper et al

PubMed record Korkushko OV, et al